Functional and molecular single-cell analyses implicate PRDM14 in the initiation of B cell leukemia in mice
Open Access
- 14 March 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-19
Abstract
The transcription factor Prdm14 is a potent oncogene implicated in the initiation of many cancers. PRDM14 resets and maintains the pluripotent state in normal cells, but the molecular mechanisms through which PRDM14 drives oncogenesis are poorly understood. Here, we interrogated the heterogeneity of Prdm14-expressing cells in a T cell lymphoblastic leukemia/lymphoma mouse model. Using mass cytometry (CyTOF) of bone marrow at a pre-leukemic timepoint, an unexpected abnormal progenitor B cell population was identified. Prdm14-expressing progenitor B cells demonstrated short-term self-renewal and a block in differentiation when transferred to syngeneic hosts. Consistently, aged host mice succumb to a highly penetrant B-LL. Single-cell RNA-seq analyses suggests that the expression signature of these pre-leukemia cells is more consistent with that of B-1 cells than B-2 cells. B-1 cells are a self-renewing population of unconventional B cells established during embryonic development. Overlaying the chromatin binding of transcriptional marks H3K4me1 and H3K4me3 with PRDM14 suggests that PRDM14 initiates cancers through promiscuous DNA binding, activating oncogenic pathways and skewing development towards a self-renewing B-1-like phenotype. Together, our data show that Prdm14 can initiate premature T and B cell cancer programs when expressed in hematopoietic progenitor cells.Keywords
Funding Information
- National Institutes of Health (R01CA163849, R01CA163849, R01CA163849, R01CA163849, R01CA163849, R01CA163849)
- Canadian Institutes of Health Research (FRN 165973, FRN 165973, FRN 165973)
- Canadian Foundation for Innovation (37562, 37562, 37562)
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2019-07014, RGPIN-2019-07014)
This publication has 56 references indexed in Scilit:
- Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signatureExperimental Hematology, 2020
- Distinct Genetic Networks Orchestrate the Emergence of Specific Waves of Fetal and Adult B-1 and B-2 DevelopmentImmunity, 2016
- FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry dataCytometry Part A, 2015
- Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genesCancer Letters, 2014
- High expression of PRDM14 correlates with cell differentiation and is a novel prognostic marker in resected non-small cell lung cancerMedical Oncology, 2013
- Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesisThe Journal of Pathology, 2013
- A PRC2-Dependent Repressive Role of PRDM14 in Human Embryonic Stem Cells and Induced Pluripotent Stem Cell ReprogrammingStem Cells, 2013
- Hallmarks of Cancer: The Next GenerationCell, 2011
- PRDM14 suppresses expression of differentiation marker genes in human embryonic stem cellsBiochemical and Biophysical Research Communications, 2008
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006